Sam Slutsky
Stock Analyst at LifeSci Capital
(2.18)
# 2,864
Out of 4,984 analysts
3
Total ratings
66.67%
Success rate
6.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sam Slutsky
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PVLA Palvella Therapeutics | Initiates: Outperform | $90 | $54.51 | +65.11% | 1 | Aug 4, 2025 | |
ABVX ABIVAX Société Anonyme | Maintains: Outperform | $45 → $101 | $82.28 | +22.75% | 1 | Jul 23, 2025 | |
IFRX InflaRx | Upgrades: Outperform | n/a | $1.14 | - | 1 | Apr 5, 2023 |
Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $54.51
Upside: +65.11%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45 → $101
Current: $82.28
Upside: +22.75%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $1.14
Upside: -